Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chem... by García-Donas, Jesus, MD, Font, Albert, MD, Pérez-Valderrama, Begoña, MD, Virizuela, José Antonio, MD, Climent, Miquel Ángel, MD, Hernando-Polo, Susana, MD, Arranz, José Ángel, MD, del Mar Llorente, Maria, MD, Lainez, Nuria, MD, Villa-Guzmán, José Carlos, MD, Mellado, Begoña, MD, del Alba, Aránzazu González, MD, Castellano, Daniel, MD, Gallardo, Enrique, MD, Anido, Urbano, MD, del Muro, Xavier García, MD, Domènech, Montserrat, MD, Puente, Javier, MD, Morales-Barrera, Rafael, MD, Pérez-Gracia, Jose Luis, MD, Bellmunt, Joaquim, Dr

Get full text

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06) by Bellmunt, Joaquim, Dr, Trigo, José Manuel, MD, Calvo, Emiliano, MD, Carles, Joan, MD, Pérez-Gracia, José L, MD, Rubió, Jordi, MD, Virizuela, Juan Antonio, MD, López, Rafael, MD, Lázaro, Martín, MD, Albanell, Joan, MD

Get full text

Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study by Plimack, Elizabeth R, Dr, Bellmunt, Joaquim, MD, Gupta, Shilpa, MD, Berger, Raanan, MD, Chow, Laura Q M, MD, Juco, Jonathan, MD, Lunceford, Jared, PhD, Saraf, Sanatan, PhD, Perini, Rodolfo F, MD, O'Donnell, Peter H, MD

Get full text

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observa... by Garcia-Donas, Jesus, MD, Esteban, Emilio, MD, Leandro-García, Luis Javier, BSc, Castellano, Daniel E, MD, del Alba, Aranzazu González, MD, Climent, Miguel Angel, MD, Arranz, José Angel, MD, Gallardo, Enrique, MD, Puente, Javier, MD, Bellmunt, Joaquim, MD, Mellado, Begoña, MD, Martínez, Esther, MD, Moreno, Fernando, MD, Font, Albert, MD, Robledo, Mercedes, PhD, Rodríguez-Antona, Cristina, Dr

Get full text

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicent... by Rosenberg, Jonathan E, Dr, Hoffman-Censits, Jean, MD, Powles, Tom, Prof, van der Heijden, Michiel S, Prof, Balar, Arjun V, MD, Necchi, Andrea, MD, Dawson, Nancy, Prof, O'Donnell, Peter H, MD, Balmanoukian, Ani, MD, Loriot, Yohann, MD, Srinivas, Sandy, MD, Retz, Margitta M, Prof, Grivas, Petros, MD, Joseph, Richard W, MD, Galsky, Matthew D, MD, Fleming, Mark T, MD, Petrylak, Daniel P, Prof, Perez-Gracia, Jose Luis, MD, Burris, Howard A, MD, Castellano, Daniel, MD, Canil, Christina, MD, Bellmunt, Joaquim, MD, Bajorin, Dean, Prof, Nickles, Dorothee, PhD, Bourgon, Richard, PhD, Frampton, Garrett M, PhD, Cui, Na, PhD, Mariathasan, Sanjeev, PhD, Abidoye, Oyewale, MD, Fine, Gregg D, MD, Dreicer, Robert, Prof

Get full text

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial by Araujo, John C, Dr, Trudel, Géralyn C, PhD, Saad, Fred, Prof, Armstrong, Andrew J, MD, Yu, Evan Y, MD, Bellmunt, Joaquim, MD, Wilding, George, Prof, McCaffrey, John, Prof, Serrano, Sergio V, MD, Matveev, Vsevolod B, Prof, Efstathiou, Eleni, MD, Oudard, Stephane, Prof, Morris, Michael J, MD, Sizer, Bruce, MBChB, Goebell, Peter J, MD, Heidenreich, Axel, Prof, de Bono, Johann S, Prof, Begbie, Stephen, MBBS, Hong, Jun H, MD, Richardet, Eduardo, MD, Gallardo, Enrique, MD, Paliwal, Prashni, PhD, Durham, Susan, BA, Cheng, Shinta, MD, Logothetis, Christopher J, Prof

Get full text